Development of Piperazine- and Oxazine-Linked Pyrimidines as p65 Subunit Binders of NF–κB in Human Breast Cancer Cells

Nuclear factor kappa B (NF–κB) is a potential therapeutic target in breast cancer. In the current study, a new class of oxazine– and piperazine–linked pyrimidines was developed as inhibitors of NF–κB, overcoming the complexity of the oxazine structure found in nature and enabling synthesis under lab...

Full description

Bibliographic Details

Published in:	Biomedicines
Main Authors:	Akshay Ravish, Bhanuprakash C. Narasimhachar, Zhang Xi, Divakar Vishwanath, Arunkumar Mohan, Santosh L. Gaonkar, Paduvalahippe Gowdegowda Chandrashekara, Kwang Seok Ahn, Vijay Pandey, Peter E. Lobie, Basappa Basappa
Format:	Article
Language:	English
Published:	MDPI AG 2023-10-01
Subjects:	oxazines piperazines pyrimidines NF–κB Alamar Blue assay molecular docking
Online Access:	https://www.mdpi.com/2227-9059/11/10/2716